Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-88.26	-554.21	4719.48
Graham Fair Price	34.21	106.75	79.54
PEG	-56.53	0.12	-0.28
Price/Book	11.45	0.96	0.86
Price/Cash Flow	174.50	20.10	7.32
Prices/Earnings	-38.83	10.85	17.73
Price/Sales	11.25	4.24	3.81
Price/FCF	174.50	20.10	7.32
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	15960.14	0.12	< 0.005
ROA	80.08	< 0.005	< 0.005
ROE	0.01	0.02	82.21
ROIC	< 0.005	0.01	16966.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.02	-56.36
Dividends QOQ	< 0.005	< 0.005	21.23
EBIT QOQ	-1.00	161.10	15937.82
EPS QOQ	-0.63	0.88	40.71
FCF QOQ	< 0.005	-0.60	-13107.99
Revenue QOQ	0.40	< 0.005	-99.22
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	16.98	17.28	1.77
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.46	0.47	0.81
Quick Ratio	1.65	1.95	17.77
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	152.11	151.23	-0.57
Cash	119.84	140.74	17.44
Capex	-0.68	-0.65	5.44
Free Cash Flow	17.91	7.23	-59.63
Revenue	34.39	34.25	-0.39
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.58	1.87	17.90
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	546.58	6.74	-98.77
Naive Interpretation	Member

06 - Financial Health · Weak

Rating